“Shame, embarrassment, crushing debt, try and try – it’s like, what’s left for you to give?” – Mahad Minhas, MD, resident physician at the University of Michigan at Ann Arbor, describing the desperation some students feel when they do not fit into a residency program.
“It’s a double victory for these men.” – Anthony D’Amico, MD, PhD, of the Dana-Farber Cancer Institute in Boston, discussing the possible role of docetaxel in a group of men with unfavorable risk prostate cancer.
“Year after year, pharmaceutical companies are raking in record profits, straining our health care system and forcing families to choose between drugs and other essentials like food or retirement.” – Representative Carolyn Maloney (DN.Y.), chair of the House Oversight and Reform Committee, which recently released a report on drug company spending.
“[W]We found that both patients, who had many risk factors for really severe COVID-19, had a fever for two days and all of their symptoms were gone. “- Jaroslaw Bilinski, MD, PhD, of Warsaw Medical University in Poland, on the effect of fecal microbiota transplant on two hospitalized patients with COVID.
“I think the story still unfolds on the biological sexual mechanisms underlying Alzheimer’s risk, particularly from the perspective of pathological markers of tau.” – Rachel Buckley, PhD, Massachusetts General Hospital in Boston, discussing new research linking endogenous estrogen exposure to Alzheimer’s biomarkers.